| - GRCh37:
- Chr8:128479976
- GRCh38:
- Chr8:127467731
| CASC8 | | Familial prostate carcinoma | association | no assertion criteria provided |
| - GRCh37:
- Chr8:128337272-128337273
- GRCh38:
- Chr8:127325027-127325028
| CASC21, CASC8 | | Familial prostate carcinoma | association | no assertion criteria provided |
| - GRCh37:
- Chr8:128285409-128285412
- GRCh38:
- Chr8:127273164-127273167
| CASC21 | | Familial prostate carcinoma | association | no assertion criteria provided |
| - GRCh37:
- Chr8:128208369
- GRCh38:
- Chr8:127196124
| CASC19 | | Familial prostate carcinoma | association | no assertion criteria provided |
| - GRCh37:
- Chr8:128205878
- GRCh38:
- Chr8:127193633
| CASC19 | | Familial prostate carcinoma | association | no assertion criteria provided |
| - GRCh37:
- Chr8:128191672
- GRCh38:
- Chr8:127179427
| | | Familial prostate carcinoma | association | no assertion criteria provided |
| - GRCh37:
- Chr8:128104117
- GRCh38:
- Chr8:127091872
| PRNCR1 | | Familial prostate carcinoma | association | no assertion criteria provided |
| - GRCh37:
- Chr8:127941793
- GRCh38:
- Chr8:126929548
| LOC105375751 | | Familial prostate carcinoma | association | no assertion criteria provided |
| - GRCh37:
- Chr11:108168094
- GRCh38:
- Chr11:108297367
| ATM | E1664* | Familial prostate carcinoma, Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome, not provided | Pathogenic/Likely pathogenic (May 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:48032123-48032124
- GRCh38:
- Chr2:47804984-47804985
| MSH6 | R1172fs, R870fs, R1042fs | Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Familial prostate carcinoma, Lynch syndrome 5 | Pathogenic/Likely pathogenic (Feb 2, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:108159831
- GRCh38:
- Chr11:108289104
| ATM | | Familial prostate carcinoma, Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome
| Likely pathogenic (Jun 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:29085179
- GRCh38:
- Chr22:28689191
| CHEK2 | Q496*, Q275*, Q429*, Q467*, Q539* | Familial cancer of breast, not provided, Familial prostate carcinoma, Hereditary cancer-predisposing syndrome | Pathogenic/Likely pathogenic (Sep 27, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:108205807
- GRCh38:
- Chr11:108335080
| ATM, C11orf65 | D2708N | Breast and/or ovarian cancer, Hereditary cancer-predisposing syndrome, Familial prostate carcinoma, not provided, Ataxia-telangiectasia syndrome | Pathogenic/Likely pathogenic (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:46805705
- GRCh38:
- Chr17:48728343
| HOXB13 | G84E | HOXB13-related disorders, HOXB13-Related Cancer Predisposition, Prostate cancer, hereditary, 9, Hereditary cancer-predisposing syndrome, Familial prostate carcinoma, not provided, Prostate cancer susceptibility | Conflicting interpretations of pathogenicity; association (Aug 15, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:41234439
- GRCh38:
- Chr17:43082422
| BRCA1 | Q1447*, Q344*, Q1400*, Q1278*, Q1336*, Q1399*, Q1419*, Q1421*, Q295*, Q297*, Q299*, Q302*, Q303*, Q304*, Q341*, Q579*, Q1151*, Q1357*, Q1377*, Q1379*, Q1398*, Q1404*, Q1420*, Q176*, Q217*, Q235*, Q255*, Q263*, Q273*, Q317*, Q342*, Q1319*, Q1320*, Q1358*, Q1359*, Q1375*, Q1405*, Q1406*, Q1446*, Q231*, Q264*, Q274*, Q277*, Q296*, Q318*, Q343*, Q1334*, Q1335*, Q1376*, Q1380*, Q1443*, Q1445*, Q216*, Q233*, Q234*, Q256*, Q276*, Q305*, Q578* | Breast-ovarian cancer, familial, susceptibility to, 1 | Pathogenic (Sep 8, 2016) | reviewed by expert panel |